DIN 02420864 — ABILIFY MAINTENA 300 MG
ABILIFY MAINTENA is a kit; powder for suspension (sustained-release of Aripiprazole (Long-Acting Injection) marketed by OTSUKA PHARMACEUTICAL CO LTD. The full Aripiprazole (Long-Acting Injection) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02420864
- Brand name
- ABILIFY MAINTENA
- Active ingredient
- Aripiprazole (Long-Acting Injection)
- Strength
- 300 MG
- Dosage form
- KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE
- Route
- INTRAMUSCULAR
- Manufacturer
- OTSUKA PHARMACEUTICAL CO LTD
- Health Canada status
- MARKETED
- Drug class
- Atypical (second-generation) antipsychotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Aripiprazole (Long-Acting Injection) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02554569 | ABILIFY ASIMTUFII | 720 MG | SUSPENSION (EXTENDED-RELEASE) | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02554577 | ABILIFY ASIMTUFII | 960 MG | SUSPENSION (EXTENDED-RELEASE) | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02420872 | ABILIFY MAINTENA | 400 MG | KIT; POWDER FOR SUSPENSION (SUSTAINED-RELEASE | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |